New York, NY, United States of America

Marc Vimolratana


 

Average Co-Inventor Count = 11.9

ph-index = 4

Forward Citations = 47(Granted Patents)


Location History:

  • San Mateo, CA (US) (2009 - 2013)
  • San Francisco, CA (US) (2014)
  • New York, NY (US) (2017 - 2022)

Company Filing History:


Years Active: 2009-2022

Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: **Marc Vimolratana: Pioneering Innovations in Cancer Treatment**

Introduction

Marc Vimolratana, a distinguished inventor based in New York, NY, has made significant contributions to the field of pharmaceuticals, particularly focusing on cancer treatment. With an impressive portfolio of 11 patents to his name, Vimolratana's work reflects his dedication to developing innovative solutions that can potentially save lives.

Latest Patents

Among his latest innovations, Vimolratana has patented compounds that inhibit the myeloid cell leukemia 1 protein (Mcl-1). These inhibitors are crucial as they offer methods for preparation, related pharmaceutical compositions, and applications to treat various diseases and conditions, particularly cancer. His patents detail compounds of Formula I along with their pharmaceutically acceptable salts and compositions. The relevance of these compounds lies in their potential use in targeted cancer therapies, showcasing Vimolratana's commitment to advancing medicine.

Career Highlights

Marc Vimolratana is employed at Amgen Inc., a leader in biotechnology that continuously invests in innovative solutions for serious illnesses. His role at Amgen allows him to utilize his expertise in drug development and contributes to the company’s mission of transforming patient care through cutting-edge science.

Collaborations

Vimolratana collaborates with esteemed colleagues, including Sean P. Brown and Jonathan B. Houze. Together, they combine their expertise to propel advancements in pharmaceutical research, particularly in the development of new therapies aimed at treating complex health conditions like cancer.

Conclusion

Marc Vimolratana stands out as a prominent inventor whose work has the potential to impact the fields of oncology and pharmaceuticals significantly. His innovative patents and collaborations reflect a strong commitment to harnessing scientific breakthroughs for the betterment of patient health and treatment options. Through his efforts, Vimolratana contributes to a future where cancer therapies are more effective and targeted, highlighting the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…